Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00645710
What this trial is testing

Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511023
What this trial is testing

Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

Who this might be right for
Phase 2Sacituzumab TirumotecanRefractory Metastatic+2 more
M.D. Anderson Cancer Center 20
Early research (Phase 1)Ended earlyNCT03300544
What this trial is testing

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectal Adenocarcinoma+7 more
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT02728804
What this trial is testing

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Who this might be right for
Stage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon Cancer+1 more
SWOG Cancer Research Network 380
Testing effectiveness (Phase 2)Study completedNCT00028626
What this trial is testing

Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00940316
What this trial is testing

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Northwestern University 28
Testing effectiveness (Phase 2)Ended earlyNCT00006037
What this trial is testing

Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Southern California 18
Testing effectiveness (Phase 2)Study completedNCT00504153
What this trial is testing

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00303875
What this trial is testing

Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight

Who this might be right for
Breast CancerColorectal CancerProstate Cancer
Duke University 641
Large-scale testing (Phase 3)Not Yet RecruitingNCT07321847
What this trial is testing

Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer (CRC)Colon Cancer Liver MetastasesRectal Cancer+2 more
Immunophotonics, Inc. 717
Testing effectiveness (Phase 2)Study completedNCT00022698
What this trial is testing

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 67
Not applicableStudy completedNCT00122187
What this trial is testing

Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention

Who this might be right for
Colorectal Cancer
US Department of Veterans Affairs 8
Testing effectiveness (Phase 2)Study completedNCT00258232
What this trial is testing

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00020930
What this trial is testing

Cetuximab in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Large-scale testing (Phase 3)Study completedNCT00004885
What this trial is testing

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 430
Large-scale testing (Phase 3)UnknownNCT00003260
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 109
Testing effectiveness (Phase 2)Study completedNCT01652196
What this trial is testing

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
John Hays 56
Testing effectiveness (Phase 2)Study completedNCT00290615
What this trial is testing

Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Herbert Hurwitz 30
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Next Page